

How does Apremilast (Otezla) work in your body? This plain-English guide explains the mechanism of action, how long it takes to work, and how it compares to other options.
If you've been prescribed Apremilast (brand name Otezla) for psoriasis, psoriatic arthritis, or Behcet's disease, you might be wondering: how does this pill actually work? What's it doing inside my body?
Understanding how your medication works isn't just interesting — it can help you stick with treatment, manage expectations about timing, and have better conversations with your doctor. Here's the plain-English version.
Apremilast is a phosphodiesterase 4 (PDE4) inhibitor. Let's break that down in human terms.
Conditions like psoriasis and psoriatic arthritis are autoimmune diseases — your immune system mistakenly attacks your own body. In psoriasis, it attacks skin cells. In psoriatic arthritis, it attacks your joints. This overactive immune response creates inflammation: redness, swelling, pain, and those characteristic scaly patches.
The inflammation is driven by chemical messengers in your body called cytokines. Some cytokines promote inflammation (pro-inflammatory), and some calm it down (anti-inflammatory). In autoimmune conditions, the balance is tipped too far toward inflammation.
Here's where PDE4 comes in. PDE4 is an enzyme — a tiny molecular machine — found inside your immune cells. Its job is to break down a molecule called cyclic AMP (cAMP).
Think of cAMP as a "calm down" signal for your immune cells. When cAMP levels are high, immune cells produce fewer inflammatory cytokines and more anti-inflammatory ones. When PDE4 breaks down cAMP, that calming signal gets weaker, and inflammation ramps up.
Apremilast blocks PDE4. By blocking this enzyme, Apremilast prevents the breakdown of cAMP. More cAMP means a stronger "calm down" signal. Your immune cells dial back the inflammatory cytokines (like TNF-alpha, IL-23, and IL-17) and produce more anti-inflammatory ones (like IL-10).
Here's a simple analogy: imagine your immune system has a volume knob. In psoriasis, the volume is cranked up too high. Apremilast doesn't turn the volume all the way off (the way some stronger immunosuppressants do). Instead, it turns it down to a reasonable level — enough to reduce symptoms without completely shutting down your immune defenses.
Apremilast isn't a fast-acting medication. Unlike a painkiller that works in an hour, Apremilast takes time to shift the balance of inflammation in your body.
Be patient with the process. If you're not seeing results after 4-6 months, talk to your doctor about whether to continue or explore alternative treatments.
Apremilast has a half-life of about 6-9 hours, which means it takes about that long for half the drug to leave your system. That's why the standard dose is 30 mg twice daily — to maintain consistent drug levels throughout the day.
The extended-release version (Otezla XR 75 mg) is designed to release slowly, allowing for once-daily dosing.
If you stop taking Apremilast, it clears from your body within about 2-3 days. However, the inflammatory process may take longer to ramp back up, so you might not see symptoms return immediately. That said, Apremilast doesn't "cure" psoriasis or psoriatic arthritis — it manages the condition, and symptoms typically return if you stop taking it.
There are several options for treating psoriasis and psoriatic arthritis. Here's how Apremilast compares:
Biologics like Adalimumab (Humira) and Secukinumab (Cosentyx) target specific inflammatory proteins directly — like sniper rifles aimed at individual cytokines. They tend to be more effective at clearing psoriasis (higher PASI 75 response rates).
However, biologics are injectable or infused, often require refrigeration, and can suppress your immune system more significantly, increasing the risk of serious infections.
Apremilast works more broadly — turning down the overall inflammatory volume rather than blocking one specific protein. It's a pill, doesn't require refrigeration, and generally has a milder impact on immune function. Trade-off: it's less effective for some patients, especially those with severe disease.
Methotrexate is an older, cheaper systemic treatment that suppresses the immune system more broadly. It's been around for decades and costs a fraction of what Apremilast costs. However, Methotrexate requires regular blood work to monitor for liver and blood cell problems, and it can't be used during pregnancy.
Apremilast doesn't require routine lab monitoring and has fewer organ-specific toxicity concerns.
Deucravacitinib is a newer oral option — a TYK2 inhibitor approved for moderate-to-severe plaque psoriasis. It has a different mechanism of action and has shown higher efficacy rates than Apremilast in clinical trials. It's another oral option for people who want to avoid injections.
Apremilast occupies a specific niche in treatment. Your doctor might recommend it because:
For a complete overview of the medication, see What Is Apremilast? And to understand potential side effects, read our side effects guide.
Apremilast works by blocking the PDE4 enzyme, raising cAMP levels in your immune cells, and turning down the inflammation that causes psoriasis and psoriatic arthritis symptoms. It's not the most powerful option out there, but it offers a unique balance of convenience (oral dosing), safety (no routine lab monitoring), and effectiveness for many patients.
If you've been prescribed Apremilast and need help finding it or affording it, Medfinder can help you find a pharmacy with it in stock and connect you with savings programs.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.